Multi-Drug Resistant TB
Johnson & Johnson’s TB drug deal will fail to reach all those in need
A recent deal struck between Johnson & Johnson and the Global Drug Facility promises improved access to bedaquiline in a number of low income countries, but fails to address structural problems
Commitment, determination and solidarity are key to success of ‘End TB in Bangladesh’
Bangladesh’s national tuberculosis program is picking up after a blow dealt by the COVID-19 pandemic, but room for improvement remains
India’s fight against TB: Govt’s eerie silence over worsening situation, drug stock-outs
While India continues its poor performance in the global fight against TB, additional challenges are emerging in the form of Delamanid stock-outs and shortage of testing kits. Despite repeated inquiries from activists, the government keeps mum
- United Farm Workers union protests ICE arrests of farm laborers involved in union drive
- Trump’s retaliatory sanctions over Netanyahu arrest warrant halt work of International Criminal Court
- Iran reasserts its right to maintain peaceful nuclear program as US talks show new promise
- Protests in Pakistan’s Gilgit-Baltistan demand the release of detained rights activists
- 100,000 march for Palestine in The Hague as Europe marks Nakba Day
